Osseon Receives FDA Clearance for Latest Steerable VCF Product
SANTA ROSA, Calif., Oct. 24, 2012 /PRNewswire/ — Osseon(®) Therapeutics, Inc. announced today the commercial release in the U.S. of its newest product, the Osseoflex(®) SB steerable inflatable bone tamp. After successful launch and distribution in Europe, the Osseoflex SB has received FDA clearance for sale in the U.S.
Osseon will be displaying its portfolio of steerable vertebral augmentation products at the NASS (North American Spine Society) tradeshow in Dallas, TX , Booth #2914, from October 24(th)- 26(th).
Osseon Therapeutics, Inc., headquartered in Santa Rosa, CA, is dedicated to developing and commercializing state of the art medical devices for minimally invasive treatments for degenerative bone and joint disease, including the treatment of vertebral compression fractures. The company’s patented, steerable delivery system offers more treatment options than other commercial solutions as well as offering significant advantages in procedural efficiency and cost. By improving the treatment of compression fractures within the lower portion of the thoracic and the entire lumbar vertebral spine, Osseon offers new, forward thinking solutions to patients suffering from these maladies, as well as to the physicians and medical facilities that treat them. Osseon’s products are distributed globally.
For more information, visit our website at osseon.com.
Osseon(®) is a registered trademark of Osseon Therapeutics, Inc. The names of actual companies and products mentioned herein may be the trademarks of their respective owners.
SOURCE Osseon Therapeutics, Inc.